Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.


Pharmaceuticals and the Worldwide HIV Epidemic: Can a Stakeholder Model Work?
Roger Bate, Joseph Calfee, Ph.D., AEI-Brookings Joint Center for Regulatory Studies Related Publication 04-16, 8-1-04

The global AIDS pandemic has led many activists to call for scrapping the current system of pharmaceutical intellectual property rights and profit-driven innovation. Bates and Calfee argue that shifting the industry to a public interest or "stakeholder" model of drug development would likely undermine essential R&D while doing little to affect the spread of AIDS.

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000